CAS NO: | 2374740-21-1 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | AKT-IN-3 (compound E22) is a potent, orally active low hERG blockingAktinhibitor, with 1.4 nM, 1.2 nM and 1.7 nM forAkt1,Akt2andAkt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such asPKA,PKC,ROCK1,RSK1,P70S6K, andSGK. AKT-IN-3 (compound E22) inducesapoptosisand inhibits metastasis ofcancercells[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
分子量 | 526.36 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C23H23Cl2F2N5O3 | ||||||||||||||||
CAS 号 | 2374740-21-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 100 mg/mL(189.98 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |